Roslin Cells is a world leader in the isolation of new clinical grade pluripotent stem cells for use in research and therapy. Roslin Cells is committed to the development of new cell therapies. It seeks to do this by producing the highest quality pluripotent and multipotent stem cells and, in collaboration with others, developing the capacity to produce clinical grade cells of selected lineages in very large quantities.
Roslin Cells achieves its goals in a robust, ethical manner compliant with current and expected regulatory requirements. We apply the highest quality standards and employ scientific excellence in all our business activities.